nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2D6—Lomustine—brain cancer	0.1	0.187	CbGbCtD
Citalopram—CYP1A2—Carmustine—brain cancer	0.0991	0.185	CbGbCtD
Citalopram—CYP2D6—Hydroxyurea—brain cancer	0.0759	0.142	CbGbCtD
Citalopram—CYP3A4—Temozolomide—brain cancer	0.0749	0.14	CbGbCtD
Citalopram—CYP3A4—Lomustine—brain cancer	0.0637	0.119	CbGbCtD
Citalopram—CYP2E1—Etoposide—brain cancer	0.0508	0.0949	CbGbCtD
Citalopram—CYP1A2—Etoposide—brain cancer	0.0294	0.0549	CbGbCtD
Citalopram—ABCB1—Etoposide—brain cancer	0.0257	0.048	CbGbCtD
Citalopram—HTR2C—choroid plexus—brain cancer	0.0181	0.162	CbGeAlD
Citalopram—CYP3A4—Etoposide—brain cancer	0.0154	0.0288	CbGbCtD
Citalopram—HRH1—nose—brain cancer	0.007	0.0628	CbGeAlD
Citalopram—SLC6A3—telencephalic ventricle—brain cancer	0.00548	0.0491	CbGeAlD
Citalopram—HTR2C—telencephalic ventricle—brain cancer	0.0053	0.0475	CbGeAlD
Citalopram—SLC6A3—ganglion—brain cancer	0.00341	0.0306	CbGeAlD
Citalopram—HTR2C—ganglion—brain cancer	0.0033	0.0296	CbGeAlD
Citalopram—SLC6A4—ganglion—brain cancer	0.00313	0.028	CbGeAlD
Citalopram—SLC6A2—ganglion—brain cancer	0.00275	0.0247	CbGeAlD
Citalopram—SLC6A3—hindbrain—brain cancer	0.00259	0.0232	CbGeAlD
Citalopram—SLC6A4—hindbrain—brain cancer	0.00237	0.0213	CbGeAlD
Citalopram—ADRA1A—hindbrain—brain cancer	0.00194	0.0174	CbGeAlD
Citalopram—SLC6A3—brainstem—brain cancer	0.00148	0.0133	CbGeAlD
Citalopram—HTR2C—brainstem—brain cancer	0.00143	0.0129	CbGeAlD
Citalopram—SLC6A4—brainstem—brain cancer	0.00136	0.0122	CbGeAlD
Citalopram—SLC6A3—telencephalon—brain cancer	0.00132	0.0118	CbGeAlD
Citalopram—HTR2C—telencephalon—brain cancer	0.00127	0.0114	CbGeAlD
Citalopram—SLC6A4—telencephalon—brain cancer	0.00121	0.0108	CbGeAlD
Citalopram—CHRM1—telencephalon—brain cancer	0.0012	0.0108	CbGeAlD
Citalopram—SLC6A2—brainstem—brain cancer	0.0012	0.0107	CbGeAlD
Citalopram—CYP2D6—hindbrain—brain cancer	0.00114	0.0102	CbGeAlD
Citalopram—ADRA1A—brainstem—brain cancer	0.00111	0.00997	CbGeAlD
Citalopram—SLC6A2—telencephalon—brain cancer	0.00106	0.00952	CbGeAlD
Citalopram—HTR2C—medulla oblongata—brain cancer	0.001	0.00896	CbGeAlD
Citalopram—ADRA1A—telencephalon—brain cancer	0.000988	0.00885	CbGeAlD
Citalopram—SLC6A3—midbrain—brain cancer	0.000946	0.00847	CbGeAlD
Citalopram—SLC6A3—spinal cord—brain cancer	0.000923	0.00827	CbGeAlD
Citalopram—HTR2C—midbrain—brain cancer	0.000914	0.00819	CbGeAlD
Citalopram—HTR2C—spinal cord—brain cancer	0.000892	0.00799	CbGeAlD
Citalopram—SLC6A2—gonad—brain cancer	0.000887	0.00795	CbGeAlD
Citalopram—SLC6A4—midbrain—brain cancer	0.000866	0.00777	CbGeAlD
Citalopram—ABCB1—blood vessel—brain cancer	0.000862	0.00773	CbGeAlD
Citalopram—SLC6A4—spinal cord—brain cancer	0.000845	0.00758	CbGeAlD
Citalopram—SLC6A2—medulla oblongata—brain cancer	0.000835	0.00748	CbGeAlD
Citalopram—SLC6A3—head—brain cancer	0.00082	0.00735	CbGeAlD
Citalopram—HTR2C—head—brain cancer	0.000793	0.0071	CbGeAlD
Citalopram—HRH1—telencephalon—brain cancer	0.000764	0.00685	CbGeAlD
Citalopram—SLC6A4—endocrine gland—brain cancer	0.000761	0.00682	CbGeAlD
Citalopram—CHRM1—endocrine gland—brain cancer	0.000758	0.00679	CbGeAlD
Citalopram—SLC6A4—head—brain cancer	0.000751	0.00673	CbGeAlD
Citalopram—CHRM1—head—brain cancer	0.000748	0.00671	CbGeAlD
Citalopram—SLC6A3—central nervous system—brain cancer	0.000748	0.00671	CbGeAlD
Citalopram—CYP2E1—telencephalon—brain cancer	0.000735	0.00658	CbGeAlD
Citalopram—SLC6A3—cerebellum—brain cancer	0.000731	0.00656	CbGeAlD
Citalopram—HTR2C—central nervous system—brain cancer	0.000723	0.00648	CbGeAlD
Citalopram—SLC6A4—central nervous system—brain cancer	0.000686	0.00615	CbGeAlD
Citalopram—CHRM1—central nervous system—brain cancer	0.000683	0.00612	CbGeAlD
Citalopram—SLC6A2—endocrine gland—brain cancer	0.00067	0.00601	CbGeAlD
Citalopram—SLC6A2—head—brain cancer	0.000661	0.00593	CbGeAlD
Citalopram—CYP2D6—brainstem—brain cancer	0.000655	0.00587	CbGeAlD
Citalopram—CYP2B6—gonad—brain cancer	0.000653	0.00586	CbGeAlD
Citalopram—CYP2C19—endocrine gland—brain cancer	0.000631	0.00565	CbGeAlD
Citalopram—ADRA1A—endocrine gland—brain cancer	0.000623	0.00558	CbGeAlD
Citalopram—ADRA1A—head—brain cancer	0.000615	0.00551	CbGeAlD
Citalopram—SLC6A2—central nervous system—brain cancer	0.000604	0.00541	CbGeAlD
Citalopram—SLC6A3—brain—brain cancer	0.000594	0.00533	CbGeAlD
Citalopram—CYP2D6—telencephalon—brain cancer	0.000582	0.00521	CbGeAlD
Citalopram—CYP2E1—medulla oblongata—brain cancer	0.000577	0.00517	CbGeAlD
Citalopram—HTR2C—brain—brain cancer	0.000574	0.00515	CbGeAlD
Citalopram—ADRA1A—central nervous system—brain cancer	0.000561	0.00503	CbGeAlD
Citalopram—ADRA1A—cerebellum—brain cancer	0.000549	0.00492	CbGeAlD
Citalopram—SLC6A4—brain—brain cancer	0.000544	0.00488	CbGeAlD
Citalopram—CHRM1—brain—brain cancer	0.000542	0.00486	CbGeAlD
Citalopram—CYP1A2—endocrine gland—brain cancer	0.000515	0.00462	CbGeAlD
Citalopram—CYP2E1—spinal cord—brain cancer	0.000515	0.00461	CbGeAlD
Citalopram—CYP2B6—endocrine gland—brain cancer	0.000494	0.00443	CbGeAlD
Citalopram—CYP2B6—head—brain cancer	0.000487	0.00437	CbGeAlD
Citalopram—HRH1—endocrine gland—brain cancer	0.000482	0.00432	CbGeAlD
Citalopram—SLC6A2—brain—brain cancer	0.000479	0.0043	CbGeAlD
Citalopram—HRH1—head—brain cancer	0.000476	0.00427	CbGeAlD
Citalopram—CYP2E1—endocrine gland—brain cancer	0.000463	0.00415	CbGeAlD
Citalopram—CYP2E1—head—brain cancer	0.000457	0.0041	CbGeAlD
Citalopram—ADRA1A—brain—brain cancer	0.000446	0.00399	CbGeAlD
Citalopram—CYP2B6—central nervous system—brain cancer	0.000445	0.00399	CbGeAlD
Citalopram—HRH1—central nervous system—brain cancer	0.000434	0.00389	CbGeAlD
Citalopram—ABCB1—telencephalon—brain cancer	0.000418	0.00375	CbGeAlD
Citalopram—CYP2E1—central nervous system—brain cancer	0.000418	0.00374	CbGeAlD
Citalopram—CYP2E1—cerebellum—brain cancer	0.000408	0.00366	CbGeAlD
Citalopram—CYP3A4—endocrine gland—brain cancer	0.000373	0.00334	CbGeAlD
Citalopram—CYP2D6—endocrine gland—brain cancer	0.000367	0.00329	CbGeAlD
Citalopram—CYP2D6—head—brain cancer	0.000362	0.00325	CbGeAlD
Citalopram—CYP2B6—brain—brain cancer	0.000353	0.00317	CbGeAlD
Citalopram—ABCB1—gonad—brain cancer	0.000349	0.00313	CbGeAlD
Citalopram—HRH1—brain—brain cancer	0.000345	0.00309	CbGeAlD
Citalopram—ABCB1—pituitary gland—brain cancer	0.000341	0.00305	CbGeAlD
Citalopram—CYP3A4—central nervous system—brain cancer	0.000336	0.00301	CbGeAlD
Citalopram—CYP2E1—brain—brain cancer	0.000331	0.00297	CbGeAlD
Citalopram—CYP2D6—central nervous system—brain cancer	0.000331	0.00296	CbGeAlD
Citalopram—ABCB1—medulla oblongata—brain cancer	0.000329	0.00295	CbGeAlD
Citalopram—CYP2D6—cerebellum—brain cancer	0.000323	0.0029	CbGeAlD
Citalopram—Fatigue—Procarbazine—brain cancer	0.000316	0.00112	CcSEcCtD
Citalopram—Haemoglobin—Temozolomide—brain cancer	0.000313	0.00111	CcSEcCtD
Citalopram—Malaise—Hydroxyurea—brain cancer	0.000313	0.00111	CcSEcCtD
Citalopram—Pain—Procarbazine—brain cancer	0.000313	0.00111	CcSEcCtD
Citalopram—Constipation—Procarbazine—brain cancer	0.000313	0.00111	CcSEcCtD
Citalopram—Hepatitis—Temozolomide—brain cancer	0.000312	0.0011	CcSEcCtD
Citalopram—Haemorrhage—Temozolomide—brain cancer	0.000312	0.0011	CcSEcCtD
Citalopram—Dysphagia—Etoposide—brain cancer	0.000312	0.0011	CcSEcCtD
Citalopram—Leukopenia—Hydroxyurea—brain cancer	0.000311	0.0011	CcSEcCtD
Citalopram—Visual impairment—Carmustine—brain cancer	0.000311	0.0011	CcSEcCtD
Citalopram—Hypoaesthesia—Temozolomide—brain cancer	0.00031	0.0011	CcSEcCtD
Citalopram—Hallucination—Temozolomide—brain cancer	0.00031	0.0011	CcSEcCtD
Citalopram—Pharyngitis—Temozolomide—brain cancer	0.000309	0.00109	CcSEcCtD
Citalopram—Urinary tract disorder—Temozolomide—brain cancer	0.000308	0.00109	CcSEcCtD
Citalopram—Oedema peripheral—Temozolomide—brain cancer	0.000307	0.00109	CcSEcCtD
Citalopram—Bronchospasm—Etoposide—brain cancer	0.000307	0.00108	CcSEcCtD
Citalopram—Connective tissue disorder—Temozolomide—brain cancer	0.000306	0.00108	CcSEcCtD
Citalopram—Urethral disorder—Temozolomide—brain cancer	0.000306	0.00108	CcSEcCtD
Citalopram—Sweating increased—Etoposide—brain cancer	0.000304	0.00107	CcSEcCtD
Citalopram—Feeling abnormal—Procarbazine—brain cancer	0.000302	0.00107	CcSEcCtD
Citalopram—Eye disorder—Carmustine—brain cancer	0.000302	0.00107	CcSEcCtD
Citalopram—Convulsion—Hydroxyurea—brain cancer	0.000301	0.00106	CcSEcCtD
Citalopram—Visual impairment—Temozolomide—brain cancer	0.0003	0.00106	CcSEcCtD
Citalopram—ABCB1—midbrain—brain cancer	0.0003	0.00269	CbGeAlD
Citalopram—Gastrointestinal pain—Procarbazine—brain cancer	0.0003	0.00106	CcSEcCtD
Citalopram—Flushing—Carmustine—brain cancer	0.000299	0.00106	CcSEcCtD
Citalopram—Pancytopenia—Etoposide—brain cancer	0.000296	0.00105	CcSEcCtD
Citalopram—Erythema multiforme—Temozolomide—brain cancer	0.000295	0.00104	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000294	0.00104	CcSEcCtD
Citalopram—ABCB1—spinal cord—brain cancer	0.000293	0.00263	CbGeAlD
Citalopram—Discomfort—Hydroxyurea—brain cancer	0.000292	0.00103	CcSEcCtD
Citalopram—Eye disorder—Temozolomide—brain cancer	0.000291	0.00103	CcSEcCtD
Citalopram—Urticaria—Procarbazine—brain cancer	0.000291	0.00103	CcSEcCtD
Citalopram—Tinnitus—Temozolomide—brain cancer	0.000291	0.00103	CcSEcCtD
Citalopram—Body temperature increased—Procarbazine—brain cancer	0.00029	0.00102	CcSEcCtD
Citalopram—Abdominal pain—Procarbazine—brain cancer	0.00029	0.00102	CcSEcCtD
Citalopram—Cardiac disorder—Temozolomide—brain cancer	0.000289	0.00102	CcSEcCtD
Citalopram—Flushing—Temozolomide—brain cancer	0.000289	0.00102	CcSEcCtD
Citalopram—Arrhythmia—Carmustine—brain cancer	0.000288	0.00102	CcSEcCtD
Citalopram—Alopecia—Carmustine—brain cancer	0.000285	0.00101	CcSEcCtD
Citalopram—Oedema—Hydroxyurea—brain cancer	0.000284	0.001	CcSEcCtD
Citalopram—Angiopathy—Temozolomide—brain cancer	0.000283	0.001	CcSEcCtD
Citalopram—Mental disorder—Carmustine—brain cancer	0.000283	0.001	CcSEcCtD
Citalopram—Infection—Hydroxyurea—brain cancer	0.000282	0.000996	CcSEcCtD
Citalopram—Immune system disorder—Temozolomide—brain cancer	0.000282	0.000996	CcSEcCtD
Citalopram—Mediastinal disorder—Temozolomide—brain cancer	0.000281	0.000994	CcSEcCtD
Citalopram—Erythema—Carmustine—brain cancer	0.000281	0.000993	CcSEcCtD
Citalopram—Malnutrition—Carmustine—brain cancer	0.000281	0.000993	CcSEcCtD
Citalopram—Chills—Temozolomide—brain cancer	0.00028	0.000989	CcSEcCtD
Citalopram—Pneumonia—Etoposide—brain cancer	0.00028	0.000989	CcSEcCtD
Citalopram—Nervous system disorder—Hydroxyurea—brain cancer	0.000278	0.000983	CcSEcCtD
Citalopram—Infestation—Etoposide—brain cancer	0.000278	0.000983	CcSEcCtD
Citalopram—Infestation NOS—Etoposide—brain cancer	0.000278	0.000983	CcSEcCtD
Citalopram—Thrombocytopenia—Hydroxyurea—brain cancer	0.000278	0.000982	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000276	0.000974	CcSEcCtD
Citalopram—Alopecia—Temozolomide—brain cancer	0.000276	0.000974	CcSEcCtD
Citalopram—Skin disorder—Hydroxyurea—brain cancer	0.000275	0.000974	CcSEcCtD
Citalopram—Acute coronary syndrome—Etoposide—brain cancer	0.000274	0.000969	CcSEcCtD
Citalopram—Mental disorder—Temozolomide—brain cancer	0.000273	0.000966	CcSEcCtD
Citalopram—Neuropathy peripheral—Etoposide—brain cancer	0.000272	0.000963	CcSEcCtD
Citalopram—Myocardial infarction—Etoposide—brain cancer	0.000272	0.000963	CcSEcCtD
Citalopram—Back pain—Carmustine—brain cancer	0.000272	0.000961	CcSEcCtD
Citalopram—Malnutrition—Temozolomide—brain cancer	0.000271	0.00096	CcSEcCtD
Citalopram—Erythema—Temozolomide—brain cancer	0.000271	0.00096	CcSEcCtD
Citalopram—Stomatitis—Etoposide—brain cancer	0.000271	0.000958	CcSEcCtD
Citalopram—Jaundice—Etoposide—brain cancer	0.000271	0.000958	CcSEcCtD
Citalopram—Anorexia—Hydroxyurea—brain cancer	0.00027	0.000956	CcSEcCtD
Citalopram—Hypersensitivity—Procarbazine—brain cancer	0.00027	0.000955	CcSEcCtD
Citalopram—Dysgeusia—Temozolomide—brain cancer	0.000266	0.00094	CcSEcCtD
Citalopram—Vision blurred—Carmustine—brain cancer	0.000265	0.000936	CcSEcCtD
Citalopram—ABCB1—endocrine gland—brain cancer	0.000264	0.00237	CbGeAlD
Citalopram—Tremor—Carmustine—brain cancer	0.000263	0.000931	CcSEcCtD
Citalopram—Asthenia—Procarbazine—brain cancer	0.000263	0.00093	CcSEcCtD
Citalopram—Hepatobiliary disease—Etoposide—brain cancer	0.000263	0.00093	CcSEcCtD
Citalopram—Back pain—Temozolomide—brain cancer	0.000263	0.000928	CcSEcCtD
Citalopram—CYP2D6—brain—brain cancer	0.000262	0.00235	CbGeAlD
Citalopram—ABCB1—head—brain cancer	0.000261	0.00234	CbGeAlD
Citalopram—Anaemia—Carmustine—brain cancer	0.00026	0.000918	CcSEcCtD
Citalopram—Agranulocytosis—Etoposide—brain cancer	0.000259	0.000917	CcSEcCtD
Citalopram—Pruritus—Procarbazine—brain cancer	0.000259	0.000917	CcSEcCtD
Citalopram—Agitation—Carmustine—brain cancer	0.000258	0.000913	CcSEcCtD
Citalopram—Vision blurred—Temozolomide—brain cancer	0.000256	0.000905	CcSEcCtD
Citalopram—Tremor—Temozolomide—brain cancer	0.000254	0.000899	CcSEcCtD
Citalopram—Dyspnoea—Hydroxyurea—brain cancer	0.000253	0.000894	CcSEcCtD
Citalopram—Somnolence—Hydroxyurea—brain cancer	0.000252	0.000891	CcSEcCtD
Citalopram—Ill-defined disorder—Temozolomide—brain cancer	0.000252	0.000891	CcSEcCtD
Citalopram—Leukopenia—Carmustine—brain cancer	0.000251	0.000889	CcSEcCtD
Citalopram—Anaemia—Temozolomide—brain cancer	0.000251	0.000887	CcSEcCtD
Citalopram—Diarrhoea—Procarbazine—brain cancer	0.000251	0.000887	CcSEcCtD
Citalopram—Dyspepsia—Hydroxyurea—brain cancer	0.00025	0.000883	CcSEcCtD
Citalopram—Agitation—Temozolomide—brain cancer	0.000249	0.000882	CcSEcCtD
Citalopram—Hypoaesthesia—Etoposide—brain cancer	0.000248	0.000878	CcSEcCtD
Citalopram—Angioedema—Temozolomide—brain cancer	0.000248	0.000877	CcSEcCtD
Citalopram—Decreased appetite—Hydroxyurea—brain cancer	0.000246	0.000872	CcSEcCtD
Citalopram—Urinary tract disorder—Etoposide—brain cancer	0.000246	0.000871	CcSEcCtD
Citalopram—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000245	0.000866	CcSEcCtD
Citalopram—Malaise—Temozolomide—brain cancer	0.000245	0.000866	CcSEcCtD
Citalopram—Urethral disorder—Etoposide—brain cancer	0.000245	0.000865	CcSEcCtD
Citalopram—Fatigue—Hydroxyurea—brain cancer	0.000244	0.000865	CcSEcCtD
Citalopram—Vertigo—Temozolomide—brain cancer	0.000244	0.000862	CcSEcCtD
Citalopram—Convulsion—Carmustine—brain cancer	0.000243	0.000861	CcSEcCtD
Citalopram—Leukopenia—Temozolomide—brain cancer	0.000243	0.000859	CcSEcCtD
Citalopram—Hypertension—Carmustine—brain cancer	0.000242	0.000858	CcSEcCtD
Citalopram—Pain—Hydroxyurea—brain cancer	0.000242	0.000858	CcSEcCtD
Citalopram—Constipation—Hydroxyurea—brain cancer	0.000242	0.000858	CcSEcCtD
Citalopram—Dizziness—Procarbazine—brain cancer	0.000242	0.000857	CcSEcCtD
Citalopram—Palpitations—Temozolomide—brain cancer	0.00024	0.000848	CcSEcCtD
Citalopram—Chest pain—Carmustine—brain cancer	0.000239	0.000846	CcSEcCtD
Citalopram—Myalgia—Carmustine—brain cancer	0.000239	0.000846	CcSEcCtD
Citalopram—Anxiety—Carmustine—brain cancer	0.000238	0.000843	CcSEcCtD
Citalopram—ABCB1—central nervous system—brain cancer	0.000238	0.00213	CbGeAlD
Citalopram—Cough—Temozolomide—brain cancer	0.000237	0.000838	CcSEcCtD
Citalopram—Erythema multiforme—Etoposide—brain cancer	0.000236	0.000834	CcSEcCtD
Citalopram—Convulsion—Temozolomide—brain cancer	0.000235	0.000832	CcSEcCtD
Citalopram—Hypertension—Temozolomide—brain cancer	0.000234	0.000829	CcSEcCtD
Citalopram—Feeling abnormal—Hydroxyurea—brain cancer	0.000234	0.000826	CcSEcCtD
Citalopram—Eye disorder—Etoposide—brain cancer	0.000233	0.000825	CcSEcCtD
Citalopram—Vomiting—Procarbazine—brain cancer	0.000233	0.000824	CcSEcCtD
Citalopram—ABCB1—cerebellum—brain cancer	0.000232	0.00208	CbGeAlD
Citalopram—Flushing—Etoposide—brain cancer	0.000232	0.000819	CcSEcCtD
Citalopram—Cardiac disorder—Etoposide—brain cancer	0.000232	0.000819	CcSEcCtD
Citalopram—Confusional state—Carmustine—brain cancer	0.000231	0.000817	CcSEcCtD
Citalopram—Arthralgia—Temozolomide—brain cancer	0.000231	0.000817	CcSEcCtD
Citalopram—Myalgia—Temozolomide—brain cancer	0.000231	0.000817	CcSEcCtD
Citalopram—Rash—Procarbazine—brain cancer	0.000231	0.000817	CcSEcCtD
Citalopram—Dermatitis—Procarbazine—brain cancer	0.000231	0.000816	CcSEcCtD
Citalopram—Anxiety—Temozolomide—brain cancer	0.00023	0.000814	CcSEcCtD
Citalopram—Headache—Procarbazine—brain cancer	0.00023	0.000812	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000229	0.000812	CcSEcCtD
Citalopram—Oedema—Carmustine—brain cancer	0.000229	0.000811	CcSEcCtD
Citalopram—Discomfort—Temozolomide—brain cancer	0.000228	0.000807	CcSEcCtD
Citalopram—Infection—Carmustine—brain cancer	0.000228	0.000805	CcSEcCtD
Citalopram—Angiopathy—Etoposide—brain cancer	0.000226	0.000801	CcSEcCtD
Citalopram—Dry mouth—Temozolomide—brain cancer	0.000226	0.000799	CcSEcCtD
Citalopram—Immune system disorder—Etoposide—brain cancer	0.000225	0.000797	CcSEcCtD
Citalopram—Mediastinal disorder—Etoposide—brain cancer	0.000225	0.000795	CcSEcCtD
Citalopram—Thrombocytopenia—Carmustine—brain cancer	0.000224	0.000794	CcSEcCtD
Citalopram—Body temperature increased—Hydroxyurea—brain cancer	0.000224	0.000793	CcSEcCtD
Citalopram—Chills—Etoposide—brain cancer	0.000224	0.000792	CcSEcCtD
Citalopram—Tachycardia—Carmustine—brain cancer	0.000224	0.000791	CcSEcCtD
Citalopram—Confusional state—Temozolomide—brain cancer	0.000223	0.00079	CcSEcCtD
Citalopram—Anaphylactic shock—Temozolomide—brain cancer	0.000222	0.000783	CcSEcCtD
Citalopram—Oedema—Temozolomide—brain cancer	0.000222	0.000783	CcSEcCtD
Citalopram—Alopecia—Etoposide—brain cancer	0.00022	0.00078	CcSEcCtD
Citalopram—Infection—Temozolomide—brain cancer	0.00022	0.000778	CcSEcCtD
Citalopram—Anorexia—Carmustine—brain cancer	0.000218	0.000773	CcSEcCtD
Citalopram—Nausea—Procarbazine—brain cancer	0.000218	0.00077	CcSEcCtD
Citalopram—Nervous system disorder—Temozolomide—brain cancer	0.000217	0.000768	CcSEcCtD
Citalopram—Thrombocytopenia—Temozolomide—brain cancer	0.000217	0.000767	CcSEcCtD
Citalopram—Skin disorder—Temozolomide—brain cancer	0.000215	0.000761	CcSEcCtD
Citalopram—Hypotension—Carmustine—brain cancer	0.000214	0.000757	CcSEcCtD
Citalopram—Hyperhidrosis—Temozolomide—brain cancer	0.000214	0.000757	CcSEcCtD
Citalopram—Dysgeusia—Etoposide—brain cancer	0.000213	0.000752	CcSEcCtD
Citalopram—Anorexia—Temozolomide—brain cancer	0.000211	0.000747	CcSEcCtD
Citalopram—Back pain—Etoposide—brain cancer	0.00021	0.000743	CcSEcCtD
Citalopram—Hypersensitivity—Hydroxyurea—brain cancer	0.000209	0.000739	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Carmustine—brain cancer	0.000209	0.000739	CcSEcCtD
Citalopram—Muscle spasms—Etoposide—brain cancer	0.000209	0.000738	CcSEcCtD
Citalopram—Insomnia—Carmustine—brain cancer	0.000207	0.000733	CcSEcCtD
Citalopram—Paraesthesia—Carmustine—brain cancer	0.000206	0.000728	CcSEcCtD
Citalopram—Dyspnoea—Carmustine—brain cancer	0.000204	0.000723	CcSEcCtD
Citalopram—Somnolence—Carmustine—brain cancer	0.000204	0.000721	CcSEcCtD
Citalopram—Asthenia—Hydroxyurea—brain cancer	0.000203	0.000719	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000202	0.000714	CcSEcCtD
Citalopram—Ill-defined disorder—Etoposide—brain cancer	0.000202	0.000713	CcSEcCtD
Citalopram—Anaemia—Etoposide—brain cancer	0.000201	0.00071	CcSEcCtD
Citalopram—Insomnia—Temozolomide—brain cancer	0.0002	0.000709	CcSEcCtD
Citalopram—Decreased appetite—Carmustine—brain cancer	0.000199	0.000705	CcSEcCtD
Citalopram—Paraesthesia—Temozolomide—brain cancer	0.000199	0.000703	CcSEcCtD
Citalopram—Gastrointestinal disorder—Carmustine—brain cancer	0.000198	0.0007	CcSEcCtD
Citalopram—Dyspnoea—Temozolomide—brain cancer	0.000197	0.000698	CcSEcCtD
Citalopram—Somnolence—Temozolomide—brain cancer	0.000197	0.000696	CcSEcCtD
Citalopram—Pain—Carmustine—brain cancer	0.000196	0.000693	CcSEcCtD
Citalopram—Constipation—Carmustine—brain cancer	0.000196	0.000693	CcSEcCtD
Citalopram—Malaise—Etoposide—brain cancer	0.000196	0.000693	CcSEcCtD
Citalopram—Vertigo—Etoposide—brain cancer	0.000195	0.00069	CcSEcCtD
Citalopram—Dyspepsia—Temozolomide—brain cancer	0.000195	0.00069	CcSEcCtD
Citalopram—Leukopenia—Etoposide—brain cancer	0.000194	0.000688	CcSEcCtD
Citalopram—Diarrhoea—Hydroxyurea—brain cancer	0.000194	0.000686	CcSEcCtD
Citalopram—Decreased appetite—Temozolomide—brain cancer	0.000193	0.000681	CcSEcCtD
Citalopram—Gastrointestinal disorder—Temozolomide—brain cancer	0.000191	0.000676	CcSEcCtD
Citalopram—Fatigue—Temozolomide—brain cancer	0.000191	0.000675	CcSEcCtD
Citalopram—Loss of consciousness—Etoposide—brain cancer	0.000191	0.000675	CcSEcCtD
Citalopram—Cough—Etoposide—brain cancer	0.00019	0.00067	CcSEcCtD
Citalopram—Constipation—Temozolomide—brain cancer	0.000189	0.00067	CcSEcCtD
Citalopram—Pain—Temozolomide—brain cancer	0.000189	0.00067	CcSEcCtD
Citalopram—Feeling abnormal—Carmustine—brain cancer	0.000189	0.000668	CcSEcCtD
Citalopram—ABCB1—brain—brain cancer	0.000189	0.00169	CbGeAlD
Citalopram—Convulsion—Etoposide—brain cancer	0.000188	0.000666	CcSEcCtD
Citalopram—Hypertension—Etoposide—brain cancer	0.000188	0.000663	CcSEcCtD
Citalopram—Dizziness—Hydroxyurea—brain cancer	0.000187	0.000663	CcSEcCtD
Citalopram—Gastrointestinal pain—Carmustine—brain cancer	0.000187	0.000663	CcSEcCtD
Citalopram—Chest pain—Etoposide—brain cancer	0.000185	0.000654	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000184	0.000649	CcSEcCtD
Citalopram—Discomfort—Etoposide—brain cancer	0.000183	0.000646	CcSEcCtD
Citalopram—Feeling abnormal—Temozolomide—brain cancer	0.000183	0.000646	CcSEcCtD
Citalopram—Body temperature increased—Carmustine—brain cancer	0.000181	0.000641	CcSEcCtD
Citalopram—Abdominal pain—Carmustine—brain cancer	0.000181	0.000641	CcSEcCtD
Citalopram—Gastrointestinal pain—Temozolomide—brain cancer	0.000181	0.000641	CcSEcCtD
Citalopram—Vomiting—Hydroxyurea—brain cancer	0.00018	0.000638	CcSEcCtD
Citalopram—Rash—Hydroxyurea—brain cancer	0.000179	0.000632	CcSEcCtD
Citalopram—Confusional state—Etoposide—brain cancer	0.000179	0.000632	CcSEcCtD
Citalopram—Dermatitis—Hydroxyurea—brain cancer	0.000179	0.000632	CcSEcCtD
Citalopram—Headache—Hydroxyurea—brain cancer	0.000178	0.000628	CcSEcCtD
Citalopram—Anaphylactic shock—Etoposide—brain cancer	0.000177	0.000627	CcSEcCtD
Citalopram—Infection—Etoposide—brain cancer	0.000176	0.000623	CcSEcCtD
Citalopram—Urticaria—Temozolomide—brain cancer	0.000176	0.000622	CcSEcCtD
Citalopram—Abdominal pain—Temozolomide—brain cancer	0.000175	0.000619	CcSEcCtD
Citalopram—Body temperature increased—Temozolomide—brain cancer	0.000175	0.000619	CcSEcCtD
Citalopram—Thrombocytopenia—Etoposide—brain cancer	0.000174	0.000614	CcSEcCtD
Citalopram—Tachycardia—Etoposide—brain cancer	0.000173	0.000612	CcSEcCtD
Citalopram—Skin disorder—Etoposide—brain cancer	0.000172	0.000609	CcSEcCtD
Citalopram—Hyperhidrosis—Etoposide—brain cancer	0.000171	0.000606	CcSEcCtD
Citalopram—Anorexia—Etoposide—brain cancer	0.000169	0.000598	CcSEcCtD
Citalopram—Hypersensitivity—Carmustine—brain cancer	0.000169	0.000597	CcSEcCtD
Citalopram—Nausea—Hydroxyurea—brain cancer	0.000168	0.000596	CcSEcCtD
Citalopram—Hypotension—Etoposide—brain cancer	0.000166	0.000586	CcSEcCtD
Citalopram—Asthenia—Carmustine—brain cancer	0.000164	0.000582	CcSEcCtD
Citalopram—Hypersensitivity—Temozolomide—brain cancer	0.000163	0.000577	CcSEcCtD
Citalopram—Paraesthesia—Etoposide—brain cancer	0.000159	0.000563	CcSEcCtD
Citalopram—Asthenia—Temozolomide—brain cancer	0.000159	0.000562	CcSEcCtD
Citalopram—Dyspnoea—Etoposide—brain cancer	0.000158	0.000559	CcSEcCtD
Citalopram—Somnolence—Etoposide—brain cancer	0.000158	0.000557	CcSEcCtD
Citalopram—Diarrhoea—Carmustine—brain cancer	0.000157	0.000555	CcSEcCtD
Citalopram—Pruritus—Temozolomide—brain cancer	0.000157	0.000554	CcSEcCtD
Citalopram—Decreased appetite—Etoposide—brain cancer	0.000154	0.000545	CcSEcCtD
Citalopram—Gastrointestinal disorder—Etoposide—brain cancer	0.000153	0.000541	CcSEcCtD
Citalopram—Fatigue—Etoposide—brain cancer	0.000153	0.00054	CcSEcCtD
Citalopram—Dizziness—Carmustine—brain cancer	0.000152	0.000536	CcSEcCtD
Citalopram—Pain—Etoposide—brain cancer	0.000152	0.000536	CcSEcCtD
Citalopram—Constipation—Etoposide—brain cancer	0.000152	0.000536	CcSEcCtD
Citalopram—Diarrhoea—Temozolomide—brain cancer	0.000152	0.000536	CcSEcCtD
Citalopram—Dizziness—Temozolomide—brain cancer	0.000146	0.000518	CcSEcCtD
Citalopram—Feeling abnormal—Etoposide—brain cancer	0.000146	0.000517	CcSEcCtD
Citalopram—Vomiting—Carmustine—brain cancer	0.000146	0.000515	CcSEcCtD
Citalopram—Gastrointestinal pain—Etoposide—brain cancer	0.000145	0.000513	CcSEcCtD
Citalopram—Rash—Carmustine—brain cancer	0.000145	0.000511	CcSEcCtD
Citalopram—Dermatitis—Carmustine—brain cancer	0.000144	0.000511	CcSEcCtD
Citalopram—Headache—Carmustine—brain cancer	0.000144	0.000508	CcSEcCtD
Citalopram—Vomiting—Temozolomide—brain cancer	0.000141	0.000498	CcSEcCtD
Citalopram—Urticaria—Etoposide—brain cancer	0.000141	0.000498	CcSEcCtD
Citalopram—Abdominal pain—Etoposide—brain cancer	0.00014	0.000496	CcSEcCtD
Citalopram—Body temperature increased—Etoposide—brain cancer	0.00014	0.000496	CcSEcCtD
Citalopram—Rash—Temozolomide—brain cancer	0.00014	0.000494	CcSEcCtD
Citalopram—Dermatitis—Temozolomide—brain cancer	0.00014	0.000493	CcSEcCtD
Citalopram—Headache—Temozolomide—brain cancer	0.000139	0.000491	CcSEcCtD
Citalopram—Nausea—Carmustine—brain cancer	0.000136	0.000482	CcSEcCtD
Citalopram—Nausea—Temozolomide—brain cancer	0.000132	0.000465	CcSEcCtD
Citalopram—Hypersensitivity—Etoposide—brain cancer	0.000131	0.000462	CcSEcCtD
Citalopram—Asthenia—Etoposide—brain cancer	0.000127	0.00045	CcSEcCtD
Citalopram—Pruritus—Etoposide—brain cancer	0.000125	0.000444	CcSEcCtD
Citalopram—Diarrhoea—Etoposide—brain cancer	0.000121	0.000429	CcSEcCtD
Citalopram—Dizziness—Etoposide—brain cancer	0.000117	0.000415	CcSEcCtD
Citalopram—Vomiting—Etoposide—brain cancer	0.000113	0.000399	CcSEcCtD
Citalopram—Rash—Etoposide—brain cancer	0.000112	0.000395	CcSEcCtD
Citalopram—Dermatitis—Etoposide—brain cancer	0.000112	0.000395	CcSEcCtD
Citalopram—Headache—Etoposide—brain cancer	0.000111	0.000393	CcSEcCtD
Citalopram—Nausea—Etoposide—brain cancer	0.000105	0.000372	CcSEcCtD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.28e-05	0.000886	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IL2—brain cancer	6.25e-05	0.000882	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.16e-05	0.000869	CbGpPWpGaD
Citalopram—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	6.13e-05	0.000866	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.08e-05	0.000858	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ABR—brain cancer	6.08e-05	0.000858	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ABR—brain cancer	6.06e-05	0.000855	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DTX2—brain cancer	6.04e-05	0.000852	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DTX2—brain cancer	6.02e-05	0.000849	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.01e-05	0.000849	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ABR—brain cancer	5.96e-05	0.000842	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DTX2—brain cancer	5.92e-05	0.000836	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.88e-05	0.00083	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.88e-05	0.00083	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.65e-05	0.000798	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.51e-05	0.000778	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.39e-05	0.00076	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.31e-05	0.00075	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTCH2—brain cancer	5.28e-05	0.000745	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.17e-05	0.00073	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HES5—brain cancer	5.11e-05	0.000722	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—brain cancer	5.02e-05	0.000709	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STRADA—brain cancer	4.96e-05	0.000701	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—TRPC6—brain cancer	4.89e-05	0.00069	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.66e-05	0.000657	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—SHH—brain cancer	4.6e-05	0.00065	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTCH2—brain cancer	4.57e-05	0.000646	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTCH2—brain cancer	4.56e-05	0.000644	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.55e-05	0.000642	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTCH2—brain cancer	4.49e-05	0.000634	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TRPC6—brain cancer	4.44e-05	0.000627	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HES5—brain cancer	4.43e-05	0.000625	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HES5—brain cancer	4.42e-05	0.000623	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.38e-05	0.000619	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—SMO—brain cancer	4.36e-05	0.000616	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PTCH1—brain cancer	4.36e-05	0.000616	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HES5—brain cancer	4.35e-05	0.000614	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STRADA—brain cancer	4.3e-05	0.000607	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STRADA—brain cancer	4.29e-05	0.000605	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TRPC6—brain cancer	4.24e-05	0.000598	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	4.22e-05	0.000596	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STRADA—brain cancer	4.22e-05	0.000596	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP2C9—brain cancer	4.17e-05	0.000588	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	4.16e-05	0.000587	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ABR—brain cancer	4.14e-05	0.000585	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP2C9—brain cancer	4.08e-05	0.000576	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.03e-05	0.000569	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GLI2—brain cancer	4e-05	0.000565	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—SHH—brain cancer	3.99e-05	0.000563	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—SHH—brain cancer	3.98e-05	0.000561	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.93e-05	0.000554	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—SHH—brain cancer	3.91e-05	0.000552	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TRPC6—brain cancer	3.85e-05	0.000543	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TRPC6—brain cancer	3.83e-05	0.000541	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PTCH1—brain cancer	3.78e-05	0.000534	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—SMO—brain cancer	3.78e-05	0.000534	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	3.77e-05	0.000533	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—SMO—brain cancer	3.77e-05	0.000532	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PTCH1—brain cancer	3.77e-05	0.000532	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GLI1—brain cancer	3.76e-05	0.000531	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	3.71e-05	0.000524	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—SMO—brain cancer	3.71e-05	0.000524	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—VAV1—brain cancer	3.66e-05	0.000517	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.66e-05	0.000516	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ABR—brain cancer	3.59e-05	0.000507	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ABR—brain cancer	3.58e-05	0.000505	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SUFU—brain cancer	3.57e-05	0.000503	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—BSG—brain cancer	3.54e-05	0.0005	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ABR—brain cancer	3.52e-05	0.000497	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—BSG—brain cancer	3.47e-05	0.00049	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GLI2—brain cancer	3.47e-05	0.000489	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GLI2—brain cancer	3.46e-05	0.000488	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GFAP—brain cancer	3.44e-05	0.000486	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.4e-05	0.00048	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.4e-05	0.00048	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GLI2—brain cancer	3.4e-05	0.00048	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.39e-05	0.000479	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.34e-05	0.000471	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—VAV1—brain cancer	3.33e-05	0.000469	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HEY1—brain cancer	3.26e-05	0.00046	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GLI1—brain cancer	3.26e-05	0.00046	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GLI1—brain cancer	3.25e-05	0.000459	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—DLL1—brain cancer	3.2e-05	0.000451	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GLI1—brain cancer	3.2e-05	0.000451	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—VAV1—brain cancer	3.17e-05	0.000448	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—VAV1—brain cancer	3.16e-05	0.000446	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP2C9—brain cancer	3.15e-05	0.000445	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	3.11e-05	0.00044	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SUFU—brain cancer	3.09e-05	0.000436	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SUFU—brain cancer	3.08e-05	0.000435	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2C9—brain cancer	3.07e-05	0.000434	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—IDH1—brain cancer	3.05e-05	0.00043	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SUFU—brain cancer	3.03e-05	0.000428	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.01e-05	0.000424	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—brain cancer	3.01e-05	0.000424	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—IDH1—brain cancer	2.99e-05	0.000421	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GFAP—brain cancer	2.98e-05	0.000421	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.98e-05	0.00042	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GFAP—brain cancer	2.97e-05	0.000419	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GFAP—brain cancer	2.93e-05	0.000413	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP2C9—brain cancer	2.9e-05	0.000409	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—VAV1—brain cancer	2.88e-05	0.000407	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—VAV1—brain cancer	2.87e-05	0.000405	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.83e-05	0.000399	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HEY1—brain cancer	2.83e-05	0.000399	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HEY1—brain cancer	2.82e-05	0.000398	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.77e-05	0.000391	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DLL1—brain cancer	2.77e-05	0.000391	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DLL1—brain cancer	2.76e-05	0.00039	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SHH—brain cancer	2.72e-05	0.000384	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.72e-05	0.000384	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—BSG—brain cancer	2.68e-05	0.000378	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.62e-05	0.00037	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.62e-05	0.00037	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—BSG—brain cancer	2.61e-05	0.000369	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTCH1—brain cancer	2.58e-05	0.000364	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SMO—brain cancer	2.58e-05	0.000364	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—BSG—brain cancer	2.46e-05	0.000348	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2C9—brain cancer	2.45e-05	0.000346	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.41e-05	0.00034	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ENO2—brain cancer	2.41e-05	0.00034	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ENO2—brain cancer	2.36e-05	0.000333	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.36e-05	0.000333	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SHH—brain cancer	2.36e-05	0.000333	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SHH—brain cancer	2.35e-05	0.000332	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.33e-05	0.000328	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SHH—brain cancer	2.31e-05	0.000326	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—IDH1—brain cancer	2.3e-05	0.000325	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TRPC6—brain cancer	2.27e-05	0.000321	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TRPC6—brain cancer	2.27e-05	0.00032	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—IDH1—brain cancer	2.25e-05	0.000317	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SMO—brain cancer	2.23e-05	0.000315	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTCH1—brain cancer	2.23e-05	0.000315	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TRPC6—brain cancer	2.23e-05	0.000315	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTCH1—brain cancer	2.23e-05	0.000314	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SMO—brain cancer	2.23e-05	0.000314	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTCH1—brain cancer	2.19e-05	0.000309	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SMO—brain cancer	2.19e-05	0.000309	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—IDH1—brain cancer	2.12e-05	0.000299	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	2.11e-05	0.000298	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—BSG—brain cancer	2.09e-05	0.000295	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOTCH2—brain cancer	2.06e-05	0.000291	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	2.02e-05	0.000284	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	2.01e-05	0.000284	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.98e-05	0.00028	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.98e-05	0.000279	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VAV1—brain cancer	1.96e-05	0.000277	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2C9—brain cancer	1.89e-05	0.000267	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.88e-05	0.000265	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.83e-05	0.000258	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.82e-05	0.000257	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ENO2—brain cancer	1.82e-05	0.000257	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.8e-05	0.000253	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—IDH1—brain cancer	1.79e-05	0.000253	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.79e-05	0.000252	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.78e-05	0.000251	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ENO2—brain cancer	1.78e-05	0.000251	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.75e-05	0.000247	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VAV1—brain cancer	1.7e-05	0.00024	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VAV1—brain cancer	1.7e-05	0.00024	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HES1—brain cancer	1.69e-05	0.000238	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ENO2—brain cancer	1.67e-05	0.000236	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.67e-05	0.000236	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.64e-05	0.000231	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BSG—brain cancer	1.61e-05	0.000227	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.61e-05	0.000227	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SPP1—brain cancer	1.56e-05	0.00022	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2—brain cancer	1.49e-05	0.00021	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HES1—brain cancer	1.46e-05	0.000207	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.46e-05	0.000206	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HES1—brain cancer	1.46e-05	0.000206	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HES1—brain cancer	1.44e-05	0.000203	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ENO2—brain cancer	1.42e-05	0.0002	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2—brain cancer	1.42e-05	0.0002	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.41e-05	0.0002	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IRS2—brain cancer	1.41e-05	0.000199	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.39e-05	0.000197	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.39e-05	0.000196	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.39e-05	0.000196	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—IDH1—brain cancer	1.38e-05	0.000195	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.37e-05	0.000193	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SPP1—brain cancer	1.35e-05	0.000191	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SPP1—brain cancer	1.35e-05	0.00019	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.33e-05	0.000187	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2—brain cancer	1.29e-05	0.000182	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2—brain cancer	1.28e-05	0.000181	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.26e-05	0.000178	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APC—brain cancer	1.25e-05	0.000176	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.25e-05	0.000176	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IRS2—brain cancer	1.22e-05	0.000173	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IRS2—brain cancer	1.22e-05	0.000172	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.2e-05	0.00017	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.14e-05	0.00016	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CG—brain cancer	1.11e-05	0.000156	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ENO2—brain cancer	1.09e-05	0.000155	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CG—brain cancer	1.08e-05	0.000153	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000153	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APC—brain cancer	1.08e-05	0.000153	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APC—brain cancer	1.08e-05	0.000152	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000152	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APC—brain cancer	1.06e-05	0.00015	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.00015	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—brain cancer	9.85e-06	0.000139	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.82e-06	0.000139	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RELA—brain cancer	9.75e-06	0.000138	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.69e-06	0.000137	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—brain cancer	9.67e-06	0.000136	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2—brain cancer	8.78e-06	0.000124	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCND1—brain cancer	8.56e-06	0.000121	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.48e-06	0.00012	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RELA—brain cancer	8.45e-06	0.000119	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RELA—brain cancer	8.42e-06	0.000119	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ERBB2—brain cancer	8.39e-06	0.000118	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ERBB2—brain cancer	8.37e-06	0.000118	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CG—brain cancer	8.35e-06	0.000118	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RELA—brain cancer	8.29e-06	0.000117	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.24e-06	0.000116	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CG—brain cancer	8.15e-06	0.000115	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CG—brain cancer	7.68e-06	0.000108	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2—brain cancer	7.61e-06	0.000107	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2—brain cancer	7.58e-06	0.000107	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2—brain cancer	7.47e-06	0.000105	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.46e-06	0.000105	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCND1—brain cancer	7.42e-06	0.000105	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCND1—brain cancer	7.39e-06	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—brain cancer	7.39e-06	0.000104	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.34e-06	0.000104	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CTNNB1—brain cancer	7.32e-06	0.000103	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.28e-06	0.000103	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.21e-06	0.000102	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—brain cancer	6.87e-06	9.69e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—brain cancer	6.72e-06	9.48e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CG—brain cancer	6.51e-06	9.18e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—brain cancer	6.47e-06	9.12e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.45e-06	9.1e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—brain cancer	6.4e-06	9.03e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—brain cancer	6.38e-06	9.01e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.34e-06	8.95e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.28e-06	8.87e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—brain cancer	5.95e-06	8.4e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—brain cancer	5.93e-06	8.37e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—brain cancer	5.84e-06	8.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—brain cancer	5.82e-06	8.21e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—brain cancer	5.8e-06	8.19e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.71e-06	8.06e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—brain cancer	5.64e-06	7.96e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CG—brain cancer	5.02e-06	7.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—brain cancer	4.89e-06	6.89e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—brain cancer	4.87e-06	6.87e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—brain cancer	4.79e-06	6.77e-05	CbGpPWpGaD
